Arvind Chhabra

University of Virginia — United States

Immunology and Microbiology · Life Sciences

19h-index953citations48works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(25), CAR-T cell therapy research(18), Immune Cell Function and Interaction(14), T-cell and B-cell Immunology(8), Cancer Immunotherapy and Biomarkers(6)

Publications48 total

Successfully Treated Upper-Extremity Necrotizing Fasciitis Caused by Photobacterium damselae
Journal of Hand Surgery Global Online·2022· 1 citedOpen Access
List of contributors
Elsevier eBooks·2022
Nanopolysaccharides and pharmaceutical applications
Elsevier eBooks·2022
Medical tourism in the COVID-19 era: opportunities, challenges and the way ahead
Worldwide Hospitality and Tourism Themes·2021· 25 cited
Synthesis, Characterization and Photocatalytic Activity of Tin Oxide Nanocrystals
Current Nanoscience·2021· 4 cited
Green Synthesis of Copper Oxide Nanoparticles using Cucumis Sativus (Cucumber) Extracts and their Bio-Physical and Biochemical Characterization for Cosmetic and Dermatologic Applications
Endocrine Metabolic & Immune Disorders - Drug Targets·2020· 21 cited
Vitamin D modulates human macrophage response to Mycobacterium tuberculosis DNA
Tuberculosis·2019· 21 citedOpen Access
A Murine Model for Human ECO Syndrome Reveals a Critical Role of Intestinal Cell Kinase in Skeletal Development
Calcified Tissue International·2017· 12 citedOpen Access
Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances
Stem Cell Reviews and Reports·2017· 40 cited
Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy
Frontiers in Immunology·2017· 16 citedOpen Access
Human Dendritic Cell–Derived Induced Pluripotent Stem Cell Lines Are Not Immunogenic
The Journal of Immunology·2017· 12 citedOpen Access
Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53
Expert Opinion on Therapeutic Targets·2016· 7 cited
Suppression of inducible CD4 regulatory cells by MHC class I-restricted human tumor epitope specific TCR engineered multifunctional CD4 T cells
Human Immunology·2016· 1 cited
Functional antigen presenting cells generated from human dendritic cells (DC) derived induced pluripotent stem cell lines
Journal for ImmunoTherapy of Cancer·2015· 1 citedOpen Access
Engineering customized anti-tumor immune response: Biology of MHC class I restricted TCR engineered CD4 T cells
Journal of Molecular and Genetic Medicine·2015
Cancer Immunotherapy: Targeting Checkpoint Blockade
Advancements in Genetic Engineering·2015· 1 citedOpen Access
SUCCESSFUL ACHILLES TENDON REGENERATION USING A BIORESORBABLE NANOFIBRE SCAFFOLD, STEM CELLS, AND GROWTH FACTOR IN A RAT TENDON GAP DEFECT MODEL
Journal of Bone and Joint Surgery-british Volume·2014
Advances in Genome Engineering Approaches
Advancements in Genetic Engineering·2014· 1 citedOpen Access
Death Receptor–Independent Activation-Induced Cell Death in Human Melanoma Antigen–Specific MHC Class I–Restricted TCR-Engineered CD4 T Cells
The Journal of Immunology·2013· 8 citedOpen Access
MHC Class I TCR driven CD4+ antitumor T Cells for cancer immunotherapy.
Journal of Vaccines & Vaccination·2013
page 1 of 3Next →

Frequent Co-authors

Nitya G. Chakraborty(18), Bijay Mukherji(18), Shikhar Mehrotra(10), Swagatam Ray(7), David I. Dorsky(7), Upendra P. Hegde(6), James S. Economou(6), Subhasis Chattopadhyay(5), Antoni Ribas(5), Monika Vats(5), Roshan James(3), Deepika Batra(3), Cato T. Laurencin(2), G. Balian(2), Richard C. Koya(2), Raja Das(2), MaCalus V. Hogan(2), Gaurav Choudhary(2), Mukul Taliyan(2), Salprima Yudha S.(2)